Pär‐Ola Bendahl

9.9k total citations
181 papers, 6.7k citations indexed

About

Pär‐Ola Bendahl is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Pär‐Ola Bendahl has authored 181 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 100 papers in Cancer Research and 37 papers in Pathology and Forensic Medicine. Recurrent topics in Pär‐Ola Bendahl's work include Breast Cancer Treatment Studies (61 papers), HER2/EGFR in Cancer Research (36 papers) and Cancer Genomics and Diagnostics (27 papers). Pär‐Ola Bendahl is often cited by papers focused on Breast Cancer Treatment Studies (61 papers), HER2/EGFR in Cancer Research (36 papers) and Cancer Genomics and Diagnostics (27 papers). Pär‐Ola Bendahl collaborates with scholars based in Sweden, Denmark and United States. Pär‐Ola Bendahl's co-authors include Mårten Fernö, Lisa Rydén, Åke Borg, Dorthe Grabau, Lao H. Saal, Sofia K. Gruvberger-Saal, Mef Nilbert, Cecilia Hegardt, Markus Ringnér and Kristina Lövgren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Pär‐Ola Bendahl

175 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pär‐Ola Bendahl Sweden	44	3.3k	3.0k	2.7k	1.4k	928	181	6.7k
Lisa Rydén Sweden	44	2.7k 0.8×	2.8k 1.0×	2.1k 0.8×	1.1k 0.8×	772 0.8×	187	5.7k
Dilip D. Giri United States	37	2.9k 0.9×	2.4k 0.8×	3.0k 1.1×	712 0.5×	728 0.8×	94	7.0k
Ludovic Lacroix France	47	2.7k 0.8×	2.0k 0.7×	2.7k 1.0×	2.3k 1.7×	515 0.6×	220	7.5k
Gamze Karaca United States	28	4.6k 1.4×	4.3k 1.5×	3.4k 1.3×	1.2k 0.9×	1.3k 1.4×	40	9.6k
Rinat Yerushalmi Israel	27	4.4k 1.3×	2.3k 0.8×	2.2k 0.8×	1.8k 1.3×	1.2k 1.3×	119	6.7k
Bjørn Naume Norway	45	3.4k 1.0×	3.1k 1.1×	2.5k 0.9×	1.1k 0.8×	615 0.7×	134	6.7k
Daniele Generali Italy	42	3.1k 0.9×	2.1k 0.7×	2.5k 0.9×	1.7k 1.3×	396 0.4×	232	6.2k
Henri Roché France	44	6.4k 2.0×	3.3k 1.1×	2.1k 0.8×	1.8k 1.3×	1.3k 1.4×	213	9.0k
Hirotaka Iwase Japan	47	3.0k 0.9×	2.2k 0.8×	2.9k 1.1×	840 0.6×	1.5k 1.6×	210	6.2k
Mark Basik Canada	41	2.8k 0.9×	2.9k 1.0×	3.5k 1.3×	1.0k 0.8×	428 0.5×	142	7.2k

Countries citing papers authored by Pär‐Ola Bendahl

Since Specialization

Citations

This map shows the geographic impact of Pär‐Ola Bendahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär‐Ola Bendahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär‐Ola Bendahl more than expected).

Fields of papers citing papers by Pär‐Ola Bendahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär‐Ola Bendahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär‐Ola Bendahl. The network helps show where Pär‐Ola Bendahl may publish in the future.

Co-authorship network of co-authors of Pär‐Ola Bendahl

This figure shows the co-authorship network connecting the top 25 collaborators of Pär‐Ola Bendahl. A scholar is included among the top collaborators of Pär‐Ola Bendahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär‐Ola Bendahl. Pär‐Ola Bendahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Möller, Ulrika, et al.. (2024). Model of Health-Related Quality of Life in Breast Cancer Patients Using Cross-Sectional Data: The Role of Resilience. Cancer Management and Research. Volume 16. 1545–1555.

Bendahl, Pär‐Ola, et al.. (2023). Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin. Cancers. 15(12). 3176–3176. 7 indexed citations

Marchi, Tommaso De, Gyula Pekár, Lena Tran, et al.. (2023). Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial. Molecular Oncology. 17(10). 2029–2040. 3 indexed citations

Bendahl, Pär‐Ola, Maria Ekholm, Mårten Fernö, et al.. (2020). Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up. Breast Cancer Research. 22(1). 140–140. 28 indexed citations

Larsson, Anna-Maria, Pär‐Ola Bendahl, Kristina Aaltonen, et al.. (2020). Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer. Scientific Reports. 10(1). 4484–4484. 15 indexed citations

Bendahl, Pär‐Ola, Åke Borg, Anna Ehinger, et al.. (2019). Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer. Breast Cancer Research and Treatment. 178(2). 459–467. 20 indexed citations

Isaksson, Sofi, Anthony M. George, Mats Jönsson, et al.. (2019). Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence. Acta Oncologica. 58(8). 1079–1086. 19 indexed citations

Larsson, Anna-Maria, Sara Jansson, Pär‐Ola Bendahl, et al.. (2018). Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Breast Cancer Research. 20(1). 48–48. 91 indexed citations

Ehinger, Anna, Per Malmström, Pär‐Ola Bendahl, et al.. (2016). Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Acta Oncologica. 56(1). 68–74. 51 indexed citations

10.

Bjarnadottir, Olöf, Siker Kimbung, Karin Jirström, et al.. (2015). Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial. Journal of Translational Medicine. 13(1). 133–133. 68 indexed citations

11.

Bjarnadottir, Olöf, Siker Kimbung, Ida Johansson, et al.. (2015). Global Transcriptional Changes Following Statin Treatment in Breast Cancer. Clinical Cancer Research. 21(15). 3402–3411. 45 indexed citations

12.

Ehinger, Anna, Pär‐Ola Bendahl, C.W. Elston, et al.. (2014). The role of histological grade in discrimination between Luminal A-like and Luminal B-like subtypes in a series of premenopausal breast cancer patients. Lund University Publications (Lund University). 2 indexed citations

13.

Fernö, Mårten, et al.. (2013). St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial. BMC Cancer. 13(1). 558–558. 55 indexed citations

14.

Broselid, Stefan, Benxu Cheng, Martin Sjöström, et al.. (2013). G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients. Clinical Cancer Research. 19(7). 1681–1692. 35 indexed citations

15.

Bendahl, Pär‐Ola, et al.. (2013). Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years’ follow-up. Breast Cancer Research and Treatment. 140(1). 93–104. 47 indexed citations

16.

Klintman, Marie, Carina Strand, Cecilia Ahlin, et al.. (2013). The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer. PLoS ONE. 8(12). e81902–e81902. 24 indexed citations

17.

Harbst, Katja, Johan Staaf, Martin Lauss, et al.. (2012). Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma. Clinical Cancer Research. 18(15). 4026–4036. 72 indexed citations

18.

Nilsson, Jeanette, Khalil Helou, Anikó Kovács, et al.. (2010). Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1. Cancer Research. 70(5). 2020–2029. 58 indexed citations

19.

Fernö, Mårten, et al.. (2008). [Quality assured HER2 analysis in breast cancer. Important therapeutic predictive and prognostic factor].. PubMed. 105(32-33). 2181–4. 2 indexed citations

20.

Gruvberger-Saal, Sofia K., Pär‐Ola Bendahl, Lao H. Saal, et al.. (2007). Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma. Clinical Cancer Research. 13(7). 1987–1994. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact